Partners Capital Investment Group, LLP Argenx Se Transaction History
Partners Capital Investment Group, LLP
- $3.34 Billion
- Q4 2024
A detailed history of Partners Capital Investment Group, LLP transactions in Argenx Se stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 4,309 shares of ARGX stock, worth $2.78 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,309
Previous 9,298
53.66%
Holding current value
$2.78 Million
Previous $5.04 Million
47.44%
% of portfolio
0.08%
Previous 0.09%
Shares
10 transactions
Others Institutions Holding ARGX
# of Institutions
432Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.56 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.98 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.49 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.15 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$798 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...